BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 16583358)

  • 21. Comparison of myocardial cell injury in acute cellular rejection versus acute vascular rejection in cyclosporine-treated heart transplants.
    Hook S; Caple JF; McMahon JT; Myles JL; Ratliff NB
    J Heart Lung Transplant; 1995; 14(2):351-8. PubMed ID: 7779856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression patterns of vascular endothelial growth factor in human cardiac allografts: association with rejection.
    Reinders ME; Fang JC; Wong W; Ganz P; Briscoe DM
    Transplantation; 2003 Jul; 76(1):224-30. PubMed ID: 12865814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RANTES chemokine expression is related to acute cardiac cellular rejection and infiltration by CD45RO T-lymphocytes and macrophages.
    Azzawi M; Hasleton PS; Geraghty PJ; Yonan N; Krysiak P; El-Gammal A; Deiraniya AK; Hutchinson IV
    J Heart Lung Transplant; 1998 Sep; 17(9):881-7. PubMed ID: 9773860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum cytokine levels in heart allograft recipients: correlation with findings on endomyocardial biopsy.
    Jordan SC; Czer L; Toyoda M; Galfayan K; Doan D; Fishbein M; Blanche C; Trento A
    J Heart Lung Transplant; 1993; 12(2):333-7. PubMed ID: 8476907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of B lymphocytes (CD20+) in renal allograft biopsy specimens.
    Martins HL; Silva C; Martini D; Noronha IL
    Transplant Proc; 2007 Mar; 39(2):432-4. PubMed ID: 17362749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A semiquantitative approach to the evaluation of acute cardiac allograft rejection at endomyocardial biopsy.
    Frigerio M; Bonacina E; Gronda E; Andreuzzi B; Anjos MC; De Vita C; Mangiavacchi M; Masciocco G; Oliva F; Pellegrini A
    J Heart Lung Transplant; 1997 Nov; 16(11):1087-98. PubMed ID: 9402507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.
    van Loosdregt J; van Oosterhout MF; Bruggink AH; van Wichen DF; van Kuik J; de Koning E; Baan CC; de Jonge N; Gmelig-Meyling FH; de Weger RA
    Circulation; 2006 Oct; 114(15):1599-607. PubMed ID: 17015796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of natural killer cells and macrophages on the course of acute graft rejection following allogeneic heart transplantation in the rat.
    Dresske B; Zhu X; Peters J; Brötzmann K; Fändrich F
    Transplant Proc; 1996 Dec; 28(6):3259-60. PubMed ID: 8962264
    [No Abstract]   [Full Text] [Related]  

  • 29. B cells in cluster or in a scattered pattern do not correlate with clinical outcome of renal allograft rejection.
    Scheepstra C; Bemelman FJ; van der Loos C; Rowshani AT; van Donselaar-Van der Pant KA; Idu MM; ten Berge IJ; Florquin S
    Transplantation; 2008 Sep; 86(6):772-8. PubMed ID: 18813100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endomyocardial biopsy. Pathologic findings in cardiac transplant recipients.
    Kottke-Marchant K; Ratliff NB
    Pathol Annu; 1990; 25 Pt 1():211-44. PubMed ID: 2404245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in leukocyte phenotype and interferon-gamma expression in stroma and endothelium during corneal graft rejection.
    Nicholls SM; Banerjee S; Figueiredo FC; Crome S; Mistry S; Easty DL; Dick AD
    Exp Eye Res; 2006 Aug; 83(2):339-47. PubMed ID: 16616741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endomyocardial biopsies after heart transplantation. The presence of markers indicative of activation.
    Wijngaard PL; Tuijnman WB; Gmelig Meyling FH; van der Meulen A; Huytink M; Jambroes G; Schuurman HJ
    Transplantation; 1993 Jan; 55(1):103-10. PubMed ID: 8420034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between natriuretic peptides and inflammation: proteomic evidence obtained during acute cellular cardiac allograft rejection in humans.
    Meirovich YF; Veinot JP; de Bold ML; Haddad H; Davies RA; Masters RG; Hendry PJ; de Bold AJ
    J Heart Lung Transplant; 2008 Jan; 27(1):31-7. PubMed ID: 18187084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of allograft inflammatory factor-1 (AIF-1) in acute cellular rejection of cardiac allografts.
    Zhou X; He Z; Henegar J; Allen B; Bigler S
    Cardiovasc Pathol; 2011; 20(5):e177-84. PubMed ID: 20850992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphocyte culture from endomyocardial biopsies. Effects of polyclonal T cell activators compared with interleukin-2 alone.
    Harcombe AA; Cary NR; Mullins P; Sharples LD; Schofield PM; Large SP; Wallwork J; Weissberg PL; Borysiewicz LK
    Transplantation; 1994 Dec; 58(11):1277-9. PubMed ID: 7992376
    [No Abstract]   [Full Text] [Related]  

  • 36. Phenotyping of ex vivo propagated graft-infiltrating cells-a tool to monitor rejection in the early post-operative period.
    Johnsson C; Lorant T; Quach M; Tufveson G
    Transpl Immunol; 2006 Aug; 16(2):81-7. PubMed ID: 16860709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute rejection and endomyocardial biopsy after heart transplantation.
    Urbanová D
    Cor Vasa; 1990; 32(5):395-400. PubMed ID: 2286087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
    Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K
    Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients.
    Sheshgiri R; Rouas-Freiss N; Rao V; Butany J; Ramzy D; Krawice-Radanne I; Ross HJ; Carosella ED; Delgado DH
    J Heart Lung Transplant; 2008 May; 27(5):522-7. PubMed ID: 18442718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C4d-the witness of humoral rejection.
    de Gouveia RH; Vitorino E; Ramos S; Rebocho MJ; Queirós E Melo J; Martins AP; Moura ML
    Transplant Proc; 2009 Apr; 41(3):866-7. PubMed ID: 19376374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.